Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Nontuberculous mycobacterial pulmonary disease incidence among elderly patients with bronchiectasis

Kimberly Schildknecht, Kevin L. Winthrop, D. Rebecca Prevots, Rebekah Blakney, Emily Henkle
European Respiratory Journal 2022 59: 2200018; DOI: 10.1183/13993003.00018-2022
Kimberly Schildknecht
1Oregon Health & Science University-Portland State University School of Public Health (OHSU-PSU), Portland, OR, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: kschildknecht@gmail.com
Kevin L. Winthrop
1Oregon Health & Science University-Portland State University School of Public Health (OHSU-PSU), Portland, OR, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
D. Rebecca Prevots
2National Institutes of Health, Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for D. Rebecca Prevots
Rebekah Blakney
2National Institutes of Health, Bethesda, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emily Henkle
1Oregon Health & Science University-Portland State University School of Public Health (OHSU-PSU), Portland, OR, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Emily Henkle
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Extract

Nontuberculous mycobacteria (NTM) are environmental pathogens causing disease in humans; however, not everyone exposed develops disease [1]. Those with underlying pulmonary diseases, persons over 60 years old and women have an increased risk for nontuberculous mycobacterial pulmonary disease (NTM-PD) [1, 2]. Bronchiectasis is a lung condition characterised by chronic airway dilation and inflammation, resulting in impaired mucus clearance, and is associated with NTM-PD [1–3]. Both NTM-PD and bronchiectasis are increasing in incidence in the USA [2, 3]. Although patients with bronchiectasis are at increased risk of acquiring NTM-PD [1, 2], the incidence of NTM-PD in these patients is not well described. Previous US Medicare data estimated those with bronchiectasis were 50- to 75-fold more likely to have a diagnosis of NTM-PD than those without bronchiectasis [4]. The objective of this analysis was to estimate the incidence of NTM-PD among US Medicare enrolees newly diagnosed with bronchiectasis over the age of 65 years.

Abstract

Incidence of NTM-PD was estimated among US Medicare beneficiaries newly diagnosed with bronchiectasis between 2006 and 2014. Overall incidence of NTM-PD was found to be as high as 1950 per 100 000 person-years. https://bit.ly/3iAr4o5

Acknowledgements

We thank Kevin Ng (OHSU) for technical support generating the datasets for analysis.

Footnotes

  • Conflict of interest: K.L. Winthrop reports grants from Insmed, Inc, AN2 Therapeutics, Paratek Pharmaceuticals, Redhill Biopharma; consulting fees from Insmed, Inc, AN2 Therapeutics, Paratek Pharmaceuticals, Redhill Biopharma, Spero Therapeutics; outside the submitted work. E. Henkle reports consulting fees from and participation on an advisory board for AN2 Therapeutics; outside the submitted work. All other authors have nothing to disclose.

  • Received January 4, 2022.
  • Accepted March 17, 2022.
  • The content of this work is not subject to copyright. Design and branding are copyright ©ERS 2022. For commercial reproduction rights and permissions contact permissions{at}ersnet.org
https://www.ersjournals.com/user-licence
View Full Text

ERS Members

myERS - ERS members : log in with your myERS username and password.

INDIVIDUALS

Log in Login as an individual user.

Forgot your username or password?

LIBRARY USERS

Log in through your institution

If your library has a subscription, you may already be logged in via your IP address. Otherwise you may be able to log in via one of the following routes.
You may be able to gain access using your login credentials for your institution. Contact your library if you do not have a username and password.
If your organization uses OpenAthens, you can log in using your OpenAthens username and password. To check if your institution is supported, please see this list. Contact your library for more details.
If you think you should have access, please contact your librarian or email journals@ersnet.org

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.
PreviousNext
Back to top
View this article with LENS
Vol 59 Issue 6 Table of Contents
European Respiratory Journal: 59 (6)
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Nontuberculous mycobacterial pulmonary disease incidence among elderly patients with bronchiectasis
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Nontuberculous mycobacterial pulmonary disease incidence among elderly patients with bronchiectasis
Kimberly Schildknecht, Kevin L. Winthrop, D. Rebecca Prevots, Rebekah Blakney, Emily Henkle
European Respiratory Journal Jun 2022, 59 (6) 2200018; DOI: 10.1183/13993003.00018-2022

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Nontuberculous mycobacterial pulmonary disease incidence among elderly patients with bronchiectasis
Kimberly Schildknecht, Kevin L. Winthrop, D. Rebecca Prevots, Rebekah Blakney, Emily Henkle
European Respiratory Journal Jun 2022, 59 (6) 2200018; DOI: 10.1183/13993003.00018-2022
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Shareable PDF
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

Agora

  • Dupilumab in patients with asthma and blood eosinophils ≥500 cells·µL−1
  • Inaccuracy of pulse oximetry in darker skinned patients unchanged across 32 years
Show more Agora

Research letters

  • Dupilumab in patients with asthma and blood eosinophils ≥500 cells·µL−1
  • G-protein coupled receptor 87 as a basal cell marker in IPF
Show more Research letters

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2022 by the European Respiratory Society